Misplaced Pages

Draft:Pipradimadol: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactivelyContent deleted Content addedVisualWikitext
Revision as of 11:56, 17 December 2024 editMo18ekula (talk | contribs)248 edits ←Created page with '{{Infobox drug | drug_name = Pipradimadol | image = Pipradimadol.svg | width = 250px | caption = <!-- Clinical data --> | pronounce = | tradename = | Drugs.com = | MedlinePlus = | licence_CA = | licence_EU = | DailyMedID = | licence_US = | pregnancy_AU = | pregnancy_category = | dependency_liability = | addiction_liability = | routes_of_administration = | class = | ATC_prefix = | ATC_suffix = <!-- Legal status --> | legal_status = <!--...'  Latest revision as of 22:08, 19 December 2024 edit undoBearcat (talk | contribs)Autopatrolled, Administrators1,564,926 edits WP:DRAFTNOCAT 
(8 intermediate revisions by 4 users not shown)
Line 1: Line 1:
{{Notability|date=December 2024}}
{{Infobox drug {{Infobox drug
| drug_name = Pipradimadol | drug_name = Pipradimadol
Line 59: Line 60:
}} }}


Antiserotoninergic agent, antidepressant, analgesic.<ref> Huegi, Bruno S.; Ebnoether, Anton M.; Rissi, Erwin; Gadient, Fulvio; Hauser, Daniel; Roemer, Dietmar; Buescher, Heinz H.; Petcher, Trevor J. (1983). "Synthesis and pharmacological studies of 4,4-disubstituted piperidines: a new class of compounds with potent analgesic properties". Journal of Medicinal Chemistry 26 (1): 42–50. doi:10.1021/jm00355a010.</ref> ] ('''FU 29-245''') is an analgesic, antiserotoninergic agent and potentially an antidepressant.<ref> Huegi, Bruno S.; Ebnoether, Anton M.; Rissi, Erwin; Gadient, Fulvio; Hauser, Daniel; Roemer, Dietmar; Buescher, Heinz H.; Petcher, Trevor J. (1983). "Synthesis and pharmacological studies of 4,4-disubstituted piperidines: a new class of compounds with potent analgesic properties". Journal of Medicinal Chemistry 26 (1): 42–50. doi:10.1021/jm00355a010.</ref> The pharmacology is said to be mediated through the opiate receptor. The potency is on the same order of magnitude as for morphine.

Patents:<ref>Erwin Rissi & Anton Ebnother, US4178377 (1979 to Sandoz KK).</ref><ref>Erwin Rissi & Anton Ebnother, US4248877 (1981 to Sandoz AG).</ref>
==See also== ==See also==
*] *]
Line 67: Line 70:
{{Antidepressants}} {{Antidepressants}}
{{Opioidergics}} {{Opioidergics}}

]

]
{{Drafts moved from mainspace|date=December 2024}}

Latest revision as of 22:08, 19 December 2024

The topic of this draft may not meet Misplaced Pages's general notability guideline. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. Notability should be established before publishing this draft or submitting it via the articles for creation process.
Find sources: "Pipradimadol" – news · newspapers · books · scholar · JSTOR (December 2024) (Learn how and when to remove this message)
Pipradimadol
Clinical data
Other namesFU 29-245
Identifiers
IUPAC name
  • 2--4-hydroxypiperidin-4-yl]-N-cyclohexyl-N,2-dimethylpropanamide
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC24H37ClN2O2
Molar mass421.02 g·mol
3D model (JSmol)
SMILES
  • CC(C)(C(=O)N(C)C1CCCCC1)C2(CCN(CC2)CCC3=CC=CC=C3Cl)O
InChI
  • InChI=1S/C24H37ClN2O2/c1-23(2,22(28)26(3)20-10-5-4-6-11-20)24(29)14-17-27(18-15-24)16-13-19-9-7-8-12-21(19)25/h7-9,12,20,29H,4-6,10-11,13-18H2,1-3H3
  • Key:CNIMNQJXZKALLC-UHFFFAOYSA-N

Pipradimadol (FU 29-245) is an analgesic, antiserotoninergic agent and potentially an antidepressant. The pharmacology is said to be mediated through the opiate receptor. The potency is on the same order of magnitude as for morphine.

Patents:

See also

References

  1. Huegi, Bruno S.; Ebnoether, Anton M.; Rissi, Erwin; Gadient, Fulvio; Hauser, Daniel; Roemer, Dietmar; Buescher, Heinz H.; Petcher, Trevor J. (1983). "Synthesis and pharmacological studies of 4,4-disubstituted piperidines: a new class of compounds with potent analgesic properties". Journal of Medicinal Chemistry 26 (1): 42–50. doi:10.1021/jm00355a010.
  2. Erwin Rissi & Anton Ebnother, US4178377 (1979 to Sandoz KK).
  3. Erwin Rissi & Anton Ebnother, US4248877 (1981 to Sandoz AG).
Antidepressants (N06A)
Specific reuptake inhibitors and/or receptor modulators
SSRIsTooltip Selective serotonin reuptake inhibitors
SNRIsTooltip Serotonin–norepinephrine reuptake inhibitors
NRIsTooltip Norepinephrine reuptake inhibitors
NDRIsTooltip Norepinephrine–dopamine reuptake inhibitors
NaSSAsTooltip Noradrenergic and specific serotonergic antidepressants
SARIsTooltip Serotonin antagonist and reuptake inhibitors
SMSTooltip Serotonin modulator and stimulators
Others
Tricyclic and tetracyclic antidepressants
TCAsTooltip Tricyclic antidepressants
TeCAsTooltip Tetracyclic antidepressants
Others
Monoamine oxidase inhibitors
Non-selective
MAOATooltip Monoamine oxidase A-selective
MAOBTooltip Monoamine oxidase B-selective
Adjunctive therapies
Miscellaneous
Opioid receptor modulators
μ-opioid
(MOR)
Agonists
(abridged;
full list)
Antagonists
δ-opioid
(DOR)
Agonists
Antagonists
κ-opioid
(KOR)
Agonists
Antagonists
Nociceptin
(NOP)
Agonists
Antagonists
Others
  • Others: Kyotorphin (met-enkephalin releaser/degradation stabilizer)